NRIX - Nurix Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$32.20
DETAILS
HIGH:
$36.00
LOW:
$28.00
MEDIAN:
$32.00
CONSENSUS:
$32.20
UPSIDE:
84.00%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-15 | Saltzman Edward C | director | A-Award | 31,250 | $15.86 | $496K |
| 2026-05-15 | Baynes Roy D. | director | A-Award | 31,250 | $15.86 | $496K |
| 2026-05-15 | GREGORY JULIA P | director | A-Award | 31,250 | $15.86 | $496K |
| 2026-05-15 | Silva Paul M | director | A-Award | 31,250 | $15.86 | $496K |
| 2026-05-15 | Reinsdorf Judith A | director | A-Award | 31,250 | $15.86 | $496K |
| 2026-05-15 | Kapur Anil | director | A-Award | 31,250 | $15.86 | $496K |
| 2026-05-15 | DANSEY ROGER D | director | A-Award | 31,250 | $15.86 | $496K |
| 2026-05-15 | Lacey David L. | director | A-Award | 31,250 | $15.86 | $496K |
| 2026-05-05 | van Houte Hans | officer: Chief Financial Officer | SELL | 582 | $17.18 | $10K |
| 2026-05-05 | van Houte Hans | officer: Chief Financial Officer | SELL | 13,473 | $16.58 | $223K |
| 2026-05-04 | Ring Christine | officer: Chief Legal Officer | SELL | 8,148 | $16.96 | $138K |
| 2026-05-01 | Ring Christine | officer: Chief Legal Officer | SELL | 5,394 | $16.76 | $90K |
| 2026-04-30 | Hansen Gwenn | officer: Chief Scientific Officer | SELL | 3,214 | $16.65 | $53K |
| 2026-04-30 | Hansen Gwenn | officer: Chief Scientific Officer | M-Exempt | 3,750 | -- | -- |
| 2026-04-30 | van Houte Hans | officer: Chief Financial Officer | SELL | 2,388 | $16.65 | $40K |
| 2026-04-30 | van Houte Hans | officer: Chief Financial Officer | M-Exempt | 2,000 | -- | -- |
| 2026-04-30 | Ring Christine | officer: Chief Legal Officer | M-Exempt | 3,750 | -- | -- |
| 2026-04-30 | Hansen Gwenn | officer: Chief Scientific Officer | M-Exempt | 2,858 | -- | -- |
| 2026-04-30 | van Houte Hans | officer: Chief Financial Officer | M-Exempt | 2,858 | -- | -- |
| 2026-04-30 | Ring Christine | officer: Chief Legal Officer | M-Exempt | 2,000 | -- | -- |
| 2026-04-30 | Hansen Gwenn | officer: Chief Scientific Officer | M-Exempt | 2,000 | -- | -- |
| 2026-04-30 | Ring Christine | officer: Chief Legal Officer | M-Exempt | 2,858 | -- | -- |
| 2026-04-30 | Ring Christine | officer: Chief Legal Officer | SELL | 3,214 | $16.65 | $53K |
| 2026-04-30 | van Houte Hans | officer: Chief Financial Officer | M-Exempt | 3,750 | -- | -- |
| 2026-04-02 | Ring Christine | officer: Chief Legal Officer | SELL | 8,148 | $15.24 | $124K |